首页> 外文期刊>Breast cancer >Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient’s perspective
【24h】

Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient’s perspective

机译:母乳喂养手术与经常性乳腺癌中的术中放射治疗:患者的观点

获取原文
           

摘要

Purpose When ipsilateral breast-tumor recurrence (IBTR) following breast-conserving surgery (BCS) occurs, the cure of a potentially life-threatening disease is the main goal. If, however, this is diagnosed early, prognosis is still good and patient-reported outcomes become more important. Despite the fact that many patients would prefer a further BCS, international breast cancer guidelines still recommend mastectomy, mainly because previous radiation implies limited options. Our comparative study evaluates the long-term quality-of-life and outcome in patients with IBTR who received BCS plus intraoperative radiotherapy (IORT) versus mastectomy. Methods Patients with IBTR were retrospectively divided into three groups according to the local treatment: group 1 ( n ?=?26) was treated with BCS?+?IORT; group 2 ( n ?=?35) received a standard mastectomy; group 3 ( n ?=?52) had a mastectomy with subsequent reconstruction. Outcomes were analyzed after a mean follow-up of 5 years after IBTR. Quality-of-life was evaluated by the validated questionnaire BREAST-Q in 50 patients who fulfilled the inclusion criteria. Results Quality-of-life scores varied within the groups, ranging from 51.4 to 91.3 (out of 100 points). We observed satisfactory scores in all items, with no statistical difference within the groups. Disease-free survival of all groups did not statistically differ, and overall mortality was very low (0.9%). The postinterventional complication rate was lower after BCS (19.2% versus 34.3% after mastectomy and 30.8% after mastectomy with reconstruction). Conclusion For patients with previous surgery and radiation who demand a second BCS in the recurrent situation, this surgical technique can be offered in combination with IORT. Our long-term results imply oncological safety, lower complication rate, and good patient satisfaction.
机译:目的,当哺乳期外科(BCS)之后的同侧乳腺肿瘤复发(IBTR)发生时,潜在的危及危及疾病的治愈是主要目标。然而,如果这是早期诊断的,预后仍然是良好的并且患者报告的结果变得更加重要。尽管许多患者更愿意进一步的BCS,但国际乳腺癌准则仍然建议乳房切除术,主要是因为之前的辐射意味着有限的选择。我们的比较研究评估了IBTR患者的长期生活质量和结果,他接受了BCS Plus术中放疗(IORT)与乳房切除术。方法根据局部治疗回顾性IBTR的患者分为三组:1组(N?=β26)用BCSα+η+。第2组(n?= 35)收到标准的乳房切除术;第3组(N?=β52)具有随后的重建的乳房切除术。在IBTR后5年后的平均随访后分析结果。 50名符合纳入标准的患者中经过验证的问卷乳腺Q评估了生活质量。结果寿命质量评分在群体中变化,范围从51.4到91.3(超过100分)。我们在所有物品中观察到满意的分数,群体内没有统计差异。所有群体的无病生存没有统计学意义,总体死亡率非常低(0.9%)。在BCS后期后的并发症率较低(乳房切除术后19.2%,重建乳房切除术后34.3%,重建后30.8%)。结论对先前手术和辐射的患者,在经常性情况下需求第二个BCS,可以与IORT结合提供这种手术技术。我们的长期结果意味着肿瘤安全性,较低的并发症率,良好的患者满意度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号